TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors
Clinical trial NCT06438783 · TERMINATED
Trial details
- NCT number
- NCT06438783
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-15
- Primary completion
- 2025-06-18
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.